{"schema_version":"1","generated_at":"2026-11-05T06:45:33.783Z","data_as_of":null,"url":"https://www.findmykol.com/kol/lisa-michaels","json_url":"https://www.findmykol.com/kol/lisa-michaels/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"lisa-michaels","name":"Lisa Michaels","specialty":"Pediatric Hematology-Oncology","specialty_raw":"Pediatric Hematology-Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Bayer","institution_url":"https://www.findmykol.com/institution/bayer","city":"New Brunswick","state":"NJ","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1982788931","openalex":"A5015115757"},"summary":"Lisa Michaels is an Oncology physician affiliated with Bayer. OpenAlex indexes 47 publications with 1,787 citations (h-index 20).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":47,"cited_by_count":1787,"h_index":20,"latest_activity_year":2021,"source":"works"},"publications":{"total":47,"shown":5,"withheld":42,"matched_by":"OpenAlex author record","recent":[{"title":"Safety and efficacy of BAY 94–9027, an extended‐half‐life factor VIII, during minor surgical procedures in patients with severe haemophilia A","year":2021,"journal":"Haemophilia","source_url":"https://doi.org/10.1111/hae.14319","status":"verified"},{"title":"CRISPR gene editing for sickle cell disease: one disease, differentiated approaches","year":2021,"journal":"Cell and Gene Therapy Insights","source_url":"https://doi.org/10.18609/cgti.2021.116","status":"verified"},{"title":"First-in-Human Gene Therapy Study of AAVhu37 Capsid Vector Technology in Severe Hemophilia A - BAY 2599023 has Broad Patient Eligibility and Stable and Sustained Long-Term Expression of FVIII","year":2020,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2020-139803","status":"verified"},{"title":"Safety and efficacy of BAY 94-9027, an extended-half-life factor VIII, during surgery in patients with severe hemophilia A: Results of the PROTECT VIII clinical trial","year":2019,"journal":"Thrombosis Research","source_url":"https://doi.org/10.1016/j.thromres.2019.08.023","status":"verified"},{"title":"BAY 94‐9027, a PEGylated recombinant factor VIII, exhibits a prolonged half‐life and higher area under the curve in patients with severe haemophilia A: Comprehensive pharmacokinetic assessment from clinical studies","year":2018,"journal":"Haemophilia","source_url":"https://doi.org/10.1111/hae.13561","status":"verified"}],"source":"works"},"contact":{"address_1":"195 LITTLE ALBANY ST","address_2":"THE CANCER INSTITUTE OF NEW JERSEY","city":"New Brunswick","state":"NJ","zip":"089011914","phone":"732-235-6455","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1982788931","source":"identity"},"similar":[{"name":"Scott Kasner","slug":"scott-kasner","institution":"Bayer","specialty":"Neurology","url":"https://www.findmykol.com/kol/scott-kasner","json_url":"https://www.findmykol.com/kol/scott-kasner/profile.json"},{"name":"Anthonie W.A. Lensing","slug":"anthonie-lensing-de","institution":"Bayer","url":"https://www.findmykol.com/kol/anthonie-lensing-de","json_url":"https://www.findmykol.com/kol/anthonie-lensing-de/profile.json"},{"name":"Peter Kolkhof","slug":"peter-kolkhof","institution":"Bayer","url":"https://www.findmykol.com/kol/peter-kolkhof","json_url":"https://www.findmykol.com/kol/peter-kolkhof/profile.json"},{"name":"Ariel Savina","slug":"ariel-savina","institution":"Bayer","url":"https://www.findmykol.com/kol/ariel-savina","json_url":"https://www.findmykol.com/kol/ariel-savina/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":42}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2011-01-11","collected_at":"2026-11-04T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"}},"methodology_url":"https://www.findmykol.com/about#methodology"}